News
2d
Health and Me on MSNNovo Nordisk Launches Weight Loss Drug Wegovy In ThailandWegovy's launch in Thaliand comes nearly a month after Eli Lilly launched its obesity management drug Mounjaro in India at ...
3d
Stocktwits on MSNNovo Nordisk’s Weight-Loss Drug Wegovy Launched In Thailand, Marks Entry Into Southeast AsiaNovo Nordisk (NVO) has launched its weight-loss drug Wegovy in Thailand, Reuters reported on Monday, citing an executive of ...
Novo Nordisk has launched its popular weight-loss drug Wegovy in Thailand, marking its first entry into the Southeast Asian ...
Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...
It said the declaration followed 42 days "without a new case since the last confirmed patient was discharged." ...
AIMIM chief Asaduddin Owaisi has strongly condemned the Pahalgam terror attack, calling it a grave security lapse and ...
US stocks are set to bounce back from Monday’s losses as investors nervously weighed up progress on trade talks with India ...
Unfortunately, what's good news for Eli Lilly is probably bad news for investors in Novo Nordisk and Viking Therapeutics, both of which lag Lilly in the race to develop their own easy-to-take GLP ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Novo Nordisk (NVO – Research Report) and Sanofi (SNYNF – Research Report). Discover ...
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Felix. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S (NVO)’s share was trading at $64 ...
The subcutaneous drug delivery market is anticipated to grow at a CAGR of 6.26% from US$41.704 billion in 2025 to US$56.503 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results